LongevityNext

Intelligence Database

Biomarkers

Filter and compare LongevityNext intelligence records by evidence stage, region, and sector.

Biomarkers Source-reviewed

DNAm GrimAge and GrimAge2

LN Evidence Score N/A Pending review
LN Claim Risk Score N/A Pending review
LN Commercial Maturity Score N/A Pending review
LN Clinic Transparency Score N/A Pending review
Biomarkers Source-reviewed draft

Immune Age Signals

Umbrella biomarker-signal record covering IMM-AGE, iAge, IMMAX, sc-ImmuAging, and related immune-clock approaches as distinct research-stage signals. It compares model-development, association, and trial-readiness evidence while keeping diagnostic, consumer-test, and clinical-utility claims out of scope.

LN Evidence Score 3 of 5
LN Claim Risk Score 4 of 5
LN Commercial Maturity Score 0 of 5
LN Clinic Transparency Score 0 of 5
Biomarkers Sample / unverified

Immune Age Signal (Sample)

Research-stage immune and inflammatory aging signal category. Staging draft; not diagnostic, prescriptive, or individually actionable.

LN Evidence Score 2 of 5
LN Claim Risk Score 3 of 5
LN Commercial Maturity Score 2 of 5
LN Clinic Transparency Score 0 of 5
Biomarkers Source-reviewed draft

Composite Aging Biomarker Panel

Research-stage biomarker category covering DNA methylation clocks and pace-of-aging measures. Staging draft; not diagnostic or prescriptive.

LN Evidence Score 3 of 5
LN Claim Risk Score 3 of 5
LN Commercial Maturity Score 2 of 5
LN Clinic Transparency Score 0 of 5
Opens in a new tab